YAP1 and medullary thyroid gland carcinoma: Our group confirmed miR-375 overexpression (at both tissue and serum levels) and its relationship with YAP1 nuclear loss in a larger cohort of MTC patients, supporting the impression that miR-375 represents a new molecular marker of neuroendocrine tumorigenesis.